13 Human papillomavirus (HPV) vaccines are currently utilised globally in national 14 immunisation programmes. Many new European migrants have settled in the United 15 Kingdom (UK) since the 2004 European Union expansion with approximately 91,000 Polish 16 people resident in Scotland. Following anecdotal reports from several NHS Boards within 17 Scotland of lower HPV vaccine uptake in Polish communities compared with other ethnic 18 minorities, an extract containing both forename and surname, was taken from the Scottish 19 Immunisation Recall System (SIRS) for all girls in S2 and S3 in school years 2014/15 to 20 2016/17. We then used the OnoMap algorithm software to derive ethnicity. OnoMap 21 identified between 289 and 321 age-eligible girls as Polish with significant disparity noted for 22 completed HPV vaccine uptake between UK (87.2-89.8%) and Polish ethnicities (69.7-23 77.2%) (P<0.01). Preliminary discussions with Polish families suggest that vaccine 24 programme differences, trust in medical/healthcare practitioners, and cultural influences may 25 be important drivers of acceptance.
Introduction 27
In Scotland, since 2008, school-based uptake of both the bivalent and quadrivalent HPV 28 vaccines in girls aged 12-13 has been impressive, with vaccine uptake sustained at levels 29 exceeding 90% (Sinka et al. 2014) . Implementation of the programme began as soon as the 30 school session started in August 2008 following an extensive communication campaign with 31 eye-catching, age-appropriate TV, radio and news coverage over the summer holidays. 32 Nearly all HPV vaccines for this age cohort in Scotland are offered in the school setting. 33 Despite recent communications to head teachers and school nurses from anti-HPV vaccine 34 groups in the UK, those involved in the programme remain committed to ensuring high 35 uptake of the vaccine continues. Although the vaccine programme has been successful within 36 the UK, the Republic of Ireland has observed considerable disparities in school uptake 37 associated with socioeconomic disadvantage (Migone et al., 2017) . Furthermore, while 
Results

72
The majority of girls in S3 in each of the three annual cohorts were classed as British Isles, 73 ranging from 90.2% to 91.8%. The percentage of S3 girls who were identified as Eastern 74 Europe ranged from 1.4% to 1.6%. Approximately 75% of those identified as Eastern 75 European were identified as Polish (Table 1) .
76
Uptake in Eastern European and Polish S3 girls (range 68.1-75.5%; 69.7-79.2%) was 77 significantly lower than in girls categorised as UK (87.2-89.6%) (P<0.01). The trend in 78 uptake across the three years was similar for the three different, with uptake falling in 79 2015/16 then increasing in 2016/17. The decrease in uptake in 2015/16 was larger among 80 girls classed as Eastern European and the Polish sub-group, compared with UK girls.
81
Although uptake rates rebounded in 2016/17 among all three groups, it was only the uptake 82 among UK girls that recovered to the level observed in 2014/15 (Table 1) . Consequently, HPV vaccination coverage in adolescent Polish girls is estimated at 1.5-10%.
97
This is much lower than those reported in countries where the cost of vaccinations is covered 98 from the national budget. Poland has recognised issues with vaccine hesitancy and an active 99 anti-vaccination movement (Braczkowska et al., 2017; Jaroszewska et al., 2014) . 
